Pay in 4 interest-free payments of $7.20 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
The use of DPP-4is as a comparator provided a highly comparable control group, particularly as both drugs were used in the setting of sole add-on medication to metformin, and both drugs have similar priority in the management of T2D
Generic Name: Sitagliptin phosphate US Brand Name: Januvia Drug Class: Dipeptidyl Peptidase-4 (DPP-4) Inhibitor Drug Category: Endocrinology / Oral Antidiabetic Agents / Incretin-Based Therapies Route of Administration: Oral Tablet FDA Approval Status: FDA-approved (October 2006) as a monotherapy and as an add-on to other agents for glycemic control
(Read more about the FDA decision) If youve been using a compounded GLP-1 medication for weight loss , dont worry we offer safe and FDA-approved alternatives
Prescribing an unapproved new drug outside a trial is technically illegal under the FDCA (aside from narrow compassionate-use exceptions)
US$ 28.29
US$ 28.67
US$ 20.07
